3M ESPE products solve clinical challenges
The Dental Advisor has identified five 3M ESPE products as excellent solutions to particular clinical challenges in the 2014 Clinical Problem Solvers Awards[1].
- The Intra-oral Syringe was praised for its lightweight and ergonomic design, which was found to enable precise application of impressioning material in hard to reach areas.
- Imprint 4 impression material was established as a solution to patient discomfort and long setting times when taking impressions.
- RelyX Ultimate adhesive resin cement was awarded the best alternative to the multiple products needed to prime a tooth and restoration for silica- and zirconia-based crowns.
- RelyX Unicem 2 automix cement was recognised for its dual-cure, self-adhesive properties, which prevents problems with improper setting of fiber posts.
- Impregum Penta impression material was praised as rigid and accurate enough for reseating a closed tray impression.
For more information, call 0845 602 5094 or visit www.3Mespe.co.uk
3M, ESPE, Imprint, RelyX, Impregum and Penta are trademarks of the 3M Company.
[1] The Dental Advisor, Clinical Evaluations, product Awards, 2014 Clinical Problem Solvers. Link http://www.dentaladvisor.com/clinical-evaluations/product-awards/2014-cps.shtml [Accessed 10.7.14]
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.